| 1 | Identifying differential regulatory control of <i>APOE</i> ɛ4 on African versus European haplotypes as potential therapeutic targets | 0.7 | 20 | Citations (PDF) |
| 2 | A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry | 3.3 | 56 | Citations (PDF) |
| 3 | Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population | 3.3 | 17 | Citations (PDF) |
| 4 | Increased <i>APOE</i> ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds | 0.7 | 69 | Citations (PDF) |
| 5 | Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus | 3.3 | 5 | Citations (PDF) |
| 6 | Assessment of AD‐related plasma biomarkers in diverse ancestral populations | 0.7 | 0 | Citations (PDF) |
| 7 | Does higher educational attainment influence functional capabilities among African Americans with Alzheimer’s disease? | 0.7 | 0 | Citations (PDF) |
| 8 | Ancestry‐specific intronic variants on the
<i>APOE</i>
ɛ4 haplotype influence enhancer activity and interaction with
<i>APOE</i>
promoter | 0.7 | 0 | Citations (PDF) |
| 9 | APOE‐stratified genome‐wide association analysis identifies novel Alzheimer disease candidate risk loci for African Americans | 0.7 | 3 | Citations (PDF) |
| 10 | Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin | 2.5 | 7 | Citations (PDF) |
| 11 | Comparative trans‐ethnic meta‐analysis of whole exome sequencing variation for Alzheimer’s disease (AD) in 18,402 individuals of the Alzheimer’s Disease Sequencing Project (ADSP) | 0.7 | 0 | Citations (PDF) |
| 12 | Exploring the role of Amerindian genetic ancestry and
ApoEε4
gene on Alzheimer disease in the Peruvian population | 0.7 | 0 | Citations (PDF) |
| 13 | Increased <i>APOE‐e4</i> expression is associated with reactive A1 astrocytes and may confer the difference in Alzheimer disease risk from different ancestral backgrounds | 0.7 | 1 | Citations (PDF) |
| 14 | Transcriptomic characterization of a Puerto Rican Alzheimer disease cohort implicates convergent immune‐related pathways | 0.7 | 0 | Citations (PDF) |
| 15 | Southern European genetic ancestry shows reduced APOE E4 risk for Alzheimer disease in Caribbean Hispanic population | 0.7 | 1 | Citations (PDF) |
| 16 | Identification of differential regulation of European versus African local ancestry haplotypes surrounding
ApoEε4 | 0.7 | 0 | Citations (PDF) |
| 17 | Functional analysis of candidate genes identified through whole genome sequencing in Caribbean Hispanic families for late‐onset Alzheimer disease | 0.7 | 1 | Citations (PDF) |
| 18 | The effect of global ancestry and diabetes on the 3MS score in older Puerto Ricans | 0.7 | 0 | Citations (PDF) |
| 19 | Mapping Alzheimer disease–associated regions in the African American population | 0.7 | 0 | Citations (PDF) |
| 20 | Use of local genetic ancestry to assess
<i>TOMM40</i>
-523′ and risk for Alzheimer disease | 2.7 | 16 | Citations (PDF) |
| 21 | Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer’s Disease Cohort | 2.7 | 15 | Citations (PDF) |
| 22 | Identification of Main Genetic Causes Responsible for Non-Syndromic Hearing Loss in a Peruvian Population | 2.7 | 6 | Citations (PDF) |
| 23 | The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach | 2.4 | 15 | Citations (PDF) |
| 24 | P1‐144: TRANSCRIPTOMIC ANALYSIS OF WHOLE BLOOD IN AFRICAN AMERICAN AND NON‐HISPANIC WHITE ALZHEIMER DISEASE CASES AND CONTROLS | 0.7 | 0 | Citations (PDF) |
| 25 | P2‐106: AFRICAN AMERICAN WHOLE EXOME SEQUENCING SUGGESTS RISK CODING VARIANTS IN IDH1 GENE | 0.7 | 0 | Citations (PDF) |
| 26 | Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease | 2.7 | 29 | Citations (PDF) |
| 27 | P1‐154: GENOME‐WIDE LINKAGE ANALYSES OF AFRICAN AMERICAN FAMILIES SUPPORTS EVIDENCE OF LINKAGE TO CHROMOSOME 12 | 0.7 | 0 | Citations (PDF) |
| 28 | O3‐06‐06: IDENTIFYING A PROTECTIVE VARIANT THAT LOWERS THE RISK FOR DEVELOPING AD IN APOE‐E4 CARRIERS | 0.7 | 0 | Citations (PDF) |
| 29 | Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations | 3.3 | 166 | Citations (PDF) |
| 30 | Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation | 8.4 | 227 | Citations (PDF) |
| 31 | [P2–124]: THE PUERTO RICAN ALZHEIMER DISEASE INITIATIVE (PRADI): INITIAL CLINICAL FINDINGS | 0.7 | 0 | Citations (PDF) |
| 32 | Application of kappa statistics in sequential tests for family-based design | 1.7 | 1 | Citations (PDF) |
| 33 | Application of Dempster-Schafer Method in Family-Based Association Studies | 3.7 | 0 | Citations (PDF) |
| 34 | Power Analysis of C-TDT for Small Sample Size Genome-Wide Association Studies by the Joint Use of Case-Parent Trios and Pairs | 1.4 | 1 | Citations (PDF) |
| 35 | A novel approach for small sample size family-based association studies: sequential tests | 3.6 | 3 | Citations (PDF) |
